The aim of the present study is to evaluate the prognostic role of immune cell score (based on CD3+ and CD8+ cell densities according to the principles of the Immunoscore® assay for colorectal cancer) in a cohort of surgically treated ccRCC patients with local or metastatic disease. This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.